Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.
Uyttebroek S, Chen B, Onsea J, Ruythooren F, Debaveye Y, Devolder D, Spriet I, Depypere M, Wagemans J, Lavigne R, Pirnay JP, Merabishvili M, De Munter P, Peetermans WE, Dupont L, Van Gerven L, Metsemakers WJ. Uyttebroek S, et al. Lancet Infect Dis. 2022 Aug;22(8):e208-e220. doi: 10.1016/S1473-3099(21)00612-5. Epub 2022 Mar 3. Lancet Infect Dis. 2022. PMID: 35248167 Review.
GRADE misuse in systematic reviews - Authors' reply.
Uyttebroek S, Onsea J, Van Gerven L, Metsemakers WJ. Uyttebroek S, et al. Lancet Infect Dis. 2022 May;22(5):591-592. doi: 10.1016/S1473-3099(22)00217-1. Lancet Infect Dis. 2022. PMID: 35460653 No abstract available.
How to approach complications of acute rhinosinusitis in children?
Uyttebroek S, Poelmans M, Casteels I, De Vleeschouwer S, Vermeulen F, Jorissen M, Van Gerven L. Uyttebroek S, et al. Int J Pediatr Otorhinolaryngol. 2020 Sep;136:110155. doi: 10.1016/j.ijporl.2020.110155. Epub 2020 May 30. Int J Pediatr Otorhinolaryngol. 2020. PMID: 32738622
Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol).
Onsea J, Uyttebroek S, Chen B, Wagemans J, Lood C, Van Gerven L, Spriet I, Devolder D, Debaveye Y, Depypere M, Dupont L, De Munter P, Peetermans WE, van Noort V, Merabishvili M, Pirnay JP, Lavigne R, Metsemakers WJ. Onsea J, et al. Among authors: uyttebroek s. Viruses. 2021 Aug 5;13(8):1543. doi: 10.3390/v13081543. Viruses. 2021. PMID: 34452408 Free PMC article.
Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections.
Uyttebroek S, Bessems L, Metsemakers W-J, Debaveye Y, Van Gerven L, Dupont L, Depypere M, Wagemans J, Lavigne R, Merabishvili M, Pirnay J-P, Devolder D, Spriet I, Onsea J. Uyttebroek S, et al. Microbiol Spectr. 2023 Dec 12;11(6):e0290723. doi: 10.1128/spectrum.02907-23. Epub 2023 Oct 11. Microbiol Spectr. 2023. PMID: 37819122 Free PMC article.